X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (40) 40
male (26) 26
oncology (25) 25
adult (22) 22
index medicus (22) 22
middle aged (22) 22
female (20) 20
glioblastoma (18) 18
aged (16) 16
clinical neurology (15) 15
chemotherapy (13) 13
cancer (12) 12
radiotherapy (12) 12
medicine & public health (11) 11
temozolomide (11) 11
treatment outcome (11) 11
tumors (10) 10
brain (9) 9
umcg approved (9) 9
care and treatment (8) 8
medicine, general & internal (8) 8
methylation (8) 8
neurology (8) 8
survival (8) 8
cerebrospinal fluid (7) 7
european organization (7) 7
follow-up studies (7) 7
methotrexate (7) 7
brain neoplasms - therapy (6) 6
central nervous system (6) 6
dacarbazine - analogs & derivatives (6) 6
drug therapy (6) 6
low-grade glioma (6) 6
magnetic resonance imaging (6) 6
neoplasms (6) 6
patients (6) 6
primary cns lymphoma (6) 6
rituximab (6) 6
surgery (6) 6
adjuvant temozolomide (5) 5
aged, 80 and over (5) 5
analysis (5) 5
brain neoplasms - pathology (5) 5
clinical trials (5) 5
dacarbazine - therapeutic use (5) 5
glioma (5) 5
gliomas (5) 5
high-grade gliomas (5) 5
low-grade gliomas (5) 5
medical prognosis (5) 5
oligodendroglial tumors (5) 5
oligodendroglioma (5) 5
phase-ii (5) 5
procarbazine (5) 5
response criteria (5) 5
studies (5) 5
therapy (5) 5
transplantation (5) 5
young adult (5) 5
brain cancer (4) 4
brain neoplasms - drug therapy (4) 4
brain neoplasms - mortality (4) 4
brain tumors (4) 4
brain-tumors (4) 4
clinical-trials (4) 4
combined modality therapy (4) 4
expression (4) 4
glioblastoma - pathology (4) 4
glioblastoma multiforme (4) 4
health aspects (4) 4
hematology, oncology and palliative medicine (4) 4
idh2 mutations (4) 4
immunology (4) 4
infectious diseases (4) 4
malignant glioma (4) 4
malignant gliomas (4) 4
management (4) 4
medicine (4) 4
pet imaging (4) 4
prospective studies (4) 4
quality of life (4) 4
radiation therapy (4) 4
radiation-therapy (4) 4
radiology, nuclear medicine & medical imaging (4) 4
response assessment (4) 4
retrospective studies (4) 4
survival analysis (4) 4
term-follow-up (4) 4
trial (4) 4
1p/19q (3) 3
1p/19q loss (3) 3
adolescent (3) 3
aggressive lymphoma (3) 3
analgesia (3) 3
anaplastic oligodendroglioma (3) 3
antineoplastic agents, alkylating - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
brain neoplasms - radiotherapy (3) 3
brain-tumor group (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 3, pp. 344 - 350
Journal Article
Lancet Oncology, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 943 - 953
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1521 - 1532
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1533 - 1542
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2014, Volume 9, Issue 12, p. e115687
Journal Article
Journal Article
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 09/2017, Volume 58, Issue 9, pp. 2074 - 2079
Central nervous system (CNS) involvement in systemic B-cell non-Hodgkin lymphoma (B-NHL) at diagnosis (sysCNS) is rare. We investigated the outcome of 21... 
systemic | methotrexate | Aggressive B-cell lymphoma | R-CHOP | central nervous system | PRIMARY CNS LYMPHOMA | RESPONSE CRITERIA | CHEMOIMMUNOTHERAPY | PHASE-II | CHEMOTHERAPY | TRANSPLANTATION | TRIAL | THERAPY | ONCOLOGY | RECURRENT PRIMARY CNS | HEMATOLOGY
Journal Article